Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Bladder Overdistension in Painful Bladder Syndrome
NCT01157507Phase 4Unknown
- Sponsor
- University of Perugia
- Start
- Jan 2010
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in interstitial cystitis (IC), sponsored by University of Perugia. Primary endpoints: Visual Analog Scale for Pain at 3 months and Diurnal and Nocturnal Urinary Frequency at 3 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT01157507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01157507.